Novel combinatorial strategies for boosting the efficacy of immune checkpoint inhibitors in advanced breast cancers
Author:
Funder
Fondation L’Oréal
Mujeres por Africa Foundation
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12094-021-02613-w.pdf
Reference116 articles.
1. Muraro E, Martorelli D, Turchet E, et al. A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies. Breast Cancer Res. 2011;13(6):R117. https://doi.org/10.1186/bcr3060.
2. Wein L, Savas P, Luen SJ, et al. Clinical validity and utility of tumor-infiltrating lymphocytes in routine clinical practice for breast cancer patients: current and future directions. Front Oncol. 2017;7:156. https://doi.org/10.3389/fonc.2017.00156.
3. Goodman AM, Kato S, Bazhenova L, et al. Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers. Mol Cancer Ther. 2017;16(11):2598–608.
4. Luen S, Virassamy B, Savas P, et al. The genomic landscape of breast cancer and its interaction with host immunity. Breast. 2016;29:241–50.
5. Kotoula V, Lakis S, Vlachos IS, et al. Tumor infiltrating lymphocytes affect the outcome of patients with operable triple-negative breast cancer in combination with mutated amino acid classes. PLoS ONE. 2016;11(9):e0163138.
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cyclophosphamide augments the efficacy of in situ vaccination in a mouse melanoma model;Frontiers in Oncology;2023-09-06
2. Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research;Journal of Mammary Gland Biology and Neoplasia;2023-07-14
3. An Overview of Breast Cancer Epidemiology, Risk Factors, Classification, Genetics, Diagnosis and Treatment;Vantage;2023-04-30
4. Bioinformatics combined with clinical data to analyze clinical characteristics and prognosis in patients with HER2 low expression breast cancer;Gland Surgery;2023-02
5. PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer;Journal of Experimental Medicine;2023-01-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3